Herein, we present a patient with mild COVID-19 infection who developed acute deep vein thrombosis.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:An outbreak of a new type coronavirus (COVID-19) disease firstly emerged in Wuhan City, China in December 2019, rapidly spreads across the globe.
📊
Temel Bulgular & Veri:COVID-19 predisposes a procoagulant state in severe COVID-19 cases with a significant increase in the incidence of venous thromboembolism, including both pulmonary embolism and deep vein thrombosis that appear to be associated with excessive inflammation, hypoxia, immobilization, and diffuse intravascular coagulation.
💡
Sonuç & Katkı:Herein, we present a patient with mild COVID-19 infection who developed acute deep vein thrombosis.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri
Abstract
An outbreak of a new type coronavirus (COVID-19) disease firstly emerged in Wuhan City, China in December 2019, rapidly spreads across the globe. COVID-19 predisposes a procoagulant state in severe COVID-19 cases with a significant increase in the incidence of venous thromboembolism, including both pulmonary embolism and deep vein thrombosis that appear to be associated with excessive inflammation, hypoxia, immobilization, and diffuse intravascular coagulation. As the thromboembolic risk of COVID-19 patients at home is not known, a risk assessment model for thrombosis may also be considered in these patients. Herein, we present a patient with mild COVID-19 infection who developed acute deep vein thrombosis.
🔖
Bu Makaleye Atıf Yap
TOLU, S., EREN, A., REZVANİ, A., KARAKAYA, A., BASIM, P. (2022). Acute deep vein thrombosis in a patient with mild COVID-19 infection: An unusual case report. Annals of Medical Research, Cilt: 27 - Sayı: 10, 2824–2826. https://ajindex.com/articles/446376
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506
WHO Updates, Daily Dashboard. Available at: https:// covid19.who.int. accessed date May 06, 2020
Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action [published online ahead of print, 2020 Apr 18]. Br J Haematol 2020;10.1111/bjh.16727
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62
Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, or follow-up. JACC, 2020, 6. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094-9
Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID 19. J Thromb Haemost 2020;18:1023-6
Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 2020;10.1111/bjh.16727
Günertem E, Akay T, Aliyev A, et al. Treatment and prophylaxis strategies for deep vein thrombosis during COVID-19 outbreak. Turk J Vasc Surg 2020;29(x):i-v.